Michael J. Tocci - Concepedia

Author

Michael J. Tocci

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M J Tocci, M Tocci, M. J. Tocci, M. Tocci, M.J. Tocci, Michael J Tocci, Michael J. Tocci, Michael Tocci

Publications

7.1K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Sanofi (United States)National Institutes of Health Sanofi (France)National Heart Lung and Blood Institute

About

Michael J. Tocci is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	5.8K
2	Natural Sciences	4	4	365
3	Biochemistry	3	3	246
4	Health Sciences	1	1	37
5	Social Sciences	1	1	59

Michael J. Tocci

Publications

Citations

H-Index

Page 1

	Year	Citations
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay, Nature InflammationCytokineGranulocyteImmunologyCellular Biochemistry	1992	2.6K
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin Stephen J. O’Keefe, Jun‐ichi Tamura, Randall L. Kincaid, Nature InflammationCsa-sensitive ActivationCytokineSignal TransductionSignaling Pathway	1992	854
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. Michael J. Tocci, D A Matkovich, Kathy Collier, The Journal of Immunology	1989	669
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Matthew J. Kostura, Michael J. Tocci, G Limjuco, Proceedings of the National Academy of Sciences Immune RegulationImmunologyImmunologic MechanismInnate ImmunityImmune System	1989	509
Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. Karen L. MacNaul, Nicole Chartrain, Michael W. Lark, Journal of Biological Chemistry ImmunologyPathologyCollagenase ExpressionInflammationRheumatoid Disorder	1990	403
Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice Hui Zheng, Daniel S. Fletcher, Wiesław Kozak, Immunity InflammationCytokineHost ResponseInnate Immune SystemImmunology	1995	367
Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. Betsy Frantz, E.C. Nordby, Gary D. Bren, The EMBO Journal Molecular PharmacologyMolecular PhysiologySignal TransductionMedicineNf-kappa B	1994	332
The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding Betsy Frantz, Tracey Klatt, Margaret Pang, Biochemistry P38 Kinase ActivityPyridinylimidazole Inhibitor BindingP38 KinaseMolecular BiologyActivation State	1998	200
Regulation of IkB α phosphorylation by PKC- and Ca2+-dependent signal transduction pathways N M Steffan, Gary D. Bren, Betsy Frantz, The Journal of Immunology	1995	141
Analysis of IL-1 and TNF-<i>alpha</i> gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. Karen L. MacNaul, Nancy I. Hutchinson, Janey N. Parsons, The Journal of Immunology	1990	114

Page 1